Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Feb 07, 2024 |
signed chap.28 delivered to governor |
Jan 29, 2024 |
returned to assembly passed senate 3rd reading cal.38 substituted for s8038 |
Jan 29, 2024 |
substituted by a8501 |
Jan 08, 2024 |
ordered to third reading cal.38 |
Jan 05, 2024 |
referred to rules |
Senate Bill S8038
Signed By Governor2023-2024 Legislative Session
Sponsored By
(D, WF) 46th Senate District
Current Bill Status Via A8501 - Signed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
2023-S8038 (ACTIVE) - Details
- See Assembly Version of this Bill:
- A8501
- Law Section:
- Insurance Law
- Laws Affected:
- Rpld §4902 sub§ (a) ¶14, §4903 sub§ (e-1), amd §§4902 & 4903, Ins L; rpld §4902 sub 1 ¶(1), §4903 sub 5-a, amd §§4902 & 4903, Pub Health L (as proposed in S.2677-A & A.463-A)
2023-S8038 (ACTIVE) - Summary
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
2023-S8038 (ACTIVE) - Sponsor Memo
BILL NUMBER: S8038 SPONSOR: BRESLIN TITLE OF BILL: An act to amend the insurance law and the public health law, in relation to adverse determinations related to a step therapy protocol override determination; and to repeal certain provisions of the insurance law and the public health law relating thereto PURPOSE: This is a chapter amendment that makes changes to provisions of L.2023, c.735, to require notice of adverse step therapy determinations. SUMMARY OF PROVISIONS: This legislation requires insurers to share additional information with consumers when delivering notices of adverse step therapy determinations and allows electronic delivery of such notices.
2023-S8038 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8038 I N S E N A T E January 5, 2024 ___________ Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Rules AN ACT to amend the insurance law and the public health law, in relation to adverse determinations related to a step therapy protocol override determination; and to repeal certain provisions of the insurance law and the public health law relating thereto THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 14 of subsection (a) of section 4902 of the insurance law, as added by a chapter of the laws of 2023 amending the insurance law and the public health law relating to requiring notice of adverse step therapy determinations, as proposed in legislative bills numbers S. 2677-A and A. 463-A, is REPEALED. § 2. Paragraph 5 of subsection (a) of section 4902 of the insurance law, as added by chapter 705 of the laws of 1996, subparagraph (ii) as amended by chapter 586 of the laws of 1998, is amended to read as follows: (5) (I) Establishment of a written procedure to assure that the notice of an adverse determination includes: [(i)] (A) the reasons for the determination including the clinical rationale, if any; [(ii)] (B) instructions on how to initiate standard and expedited appeals pursuant to section four thousand nine hundred four of this article and an external appeal pursuant to section four thousand nine hundred fourteen of this article; [and (iii)] (C) notice of the availability, upon request of the insured or the insured's designee, of the clinical review criteria relied upon to make such determination; (D) WHAT, IF ANY, ADDITIONAL NECESSARY INFORMATION MUST BE PROVIDED TO, OR OBTAINED BY, THE UTILIZATION REVIEW AGENT IN ORDER TO RENDER A DECISION ON APPEAL; AND (E) FOR AN ADVERSE DETERMINATION RELATED TO A STEP THERAPY PROTOCOL OVERRIDE DETERMINATION, INFORMATION THAT INCLUDES THE CLINICAL REVIEW CRITERIA RELIED UPON TO MAKE SUCH DETERMINATION AND ANY APPLICABLE EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.